Société Algernon Pharmaceuticals Inc.
Actions
AGN
CA01559R4008
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
0,125 CAD | +13,64% | +13,64% | +92,31% |
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chris Moreau
CEO | Chief Executive Officer | 59 | 01/03/18 |
James Kinley
DFI | Director of Finance/CFO | 45 | 01/12/21 |
Chief Operating Officer | 41 | 01/03/21 | |
Ahmad Khalil
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/21 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Harry Bloomfield
CHM | Chairman | 79 | 08/09/21 |
Chris Moreau
CEO | Chief Executive Officer | 59 | 01/03/18 |
Mark Williams
BRD | Director/Board Member | 52 | 22/09/21 |
James Kinley
DFI | Director of Finance/CFO | 45 | 01/12/21 |
Raj Attariwala
BRD | Director/Board Member | 55 | 26/10/15 |
Howard Gutman
BRD | Director/Board Member | - | 28/02/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 21 840 722 | 21 665 319 ( 99,20 %) | 0 | 99,20 % |
Coordonnées société
Algernon Pharmaceuticals, Inc.
601 West Broadway Street Suite 400
V5Z 4C2, Vancouver
+604-398-4175
http://www.algernonpharmaceuticals.comSecteur
Chiffre d'affaires trimestriel - Taux de surprise
Varia. 1 janv. | Capi. | |
---|---|---|
+92,31% | 2 M | |
+3,91% | 109 Md | |
+10,87% | 105 Md | |
+1,28% | 22,25 Md | |
-13,14% | 22,09 Md | |
-7,05% | 18,68 Md | |
-38,36% | 17,58 Md | |
-10,66% | 16,85 Md | |
+3,75% | 13,76 Md | |
+36,70% | 12,46 Md |
- Bourse
- Actions
- Action AGN
- Société Algernon Pharmaceuticals Inc.